Abbey Pharma Limited 06870472 false true 2013-05-01 2014-04-30 2014-04-30 06870472 2013-05-01 2014-04-30 06870472 2014-04-30 06870472 uk-bus:OrdinaryShareClass1 2014-04-30 06870472 uk-gaap:Subsidiary1 2014-04-30 06870472 uk-gaap:Subsidiary2 2014-04-30 06870472 uk-bus:Director3 2013-05-01 2014-04-30 06870472 uk-bus:OrdinaryShareClass1 2013-05-01 2014-04-30 06870472 uk-gaap:Subsidiary1 2013-05-01 2014-04-30 06870472 uk-gaap:Subsidiary2 2013-05-01 2014-04-30 06870472 2013-04-30 06870472 2013-04-30 06870472 uk-bus:OrdinaryShareClass1 2013-04-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 06870472

Abbey Pharma Limited

Unaudited Abbreviated Accounts

for the Year Ended 30 April 2014
 

 

Abbey Pharma Limited
Contents

Abbreviated Balance Sheet

1

Notes to the Abbreviated Accounts

2 to 3

 

Abbey Pharma Limited
(Registration number: 06870472)
Abbreviated Balance Sheet at 30 April 2014

   

Note

    

2014
£

    

2013
£

  

Fixed assets

  

             

Investments

  

   

357,450

   

357,450

 

Current assets

  

             

Debtors

  

   

1,965

   

1,965

 

Cash at bank and in hand

  

   

5,360

   

34,605

 
   

   

7,325

   

36,570

 

Creditors: Amounts falling due within one year

  

   

(297,274)

   

(192,175)

 

Net current liabilities

  

   

(289,949)

   

(155,605)

 

Total assets less current liabilities

  

   

67,501

   

201,845

 

Creditors: Amounts falling due after more than one year

  

   

(72,426)

   

(200,842)

 

Net (liabilities)/assets

  

   

(4,925)

   

1,003

 

Capital and reserves

  

             

Called up share capital

 

4

   

1,000

   

1,000

 

Profit and loss account

  

   

(5,925)

   

3

 

Shareholders' (deficit)/funds

  

   

(4,925)

   

1,003

 

For the year ending 30 April 2014 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime .

Approved by the Board on 15 October 2014 and signed on its behalf by:

.........................................
Mr Kevin James
Director

The notes on pages 2 to 3 form an integral part of these financial statements.
Page 1

 

Abbey Pharma Limited
Notes to the Abbreviated Accounts for the Year Ended 30 April 2014
......... continued

1

Accounting policies

Basis of preparation

The full financial statements, from which these abbreviated accounts have been extracted, have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (Effective April 2008).

Fixed asset investments

Fixed asset investments are stated at historical cost less provision for any diminution in value.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability in the balance sheet. The corresponding dividends relating to the liability component are charged as interest expense in the profit and loss account.

2

Fixed assets

   

Investments
£

    

Total
£

  

Cost

            

At 1 May 2013

  

357,450

    

357,450

  

At 30 April 2014

  

357,450

    

357,450

  

Depreciation

            

At 30 April 2014

  

-

    

-

  

Net book value

            

At 30 April 2014

  

357,450

   

357,450

 

At 30 April 2013

  

357,450

   

357,450

 

Details of undertakings

Details of the investments in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Holding

Proportion of voting rights and shares held

Principal activity

Subsidiary undertakings

Intrapharm Laboratories Limited

Ordinary £1 shares

100%

Distribution of pharmaceutical products

Page 2

 

Abbey Pharma Limited
Notes to the Abbreviated Accounts for the Year Ended 30 April 2014
......... continued

Abbey Pharmaceuticals Limited

£1 Ordinary shares

100%

Dormant company

The profit for the financial period of Intrapharm Laboratories Limited was £646,423 and the aggregate amount of capital and reserves at the end of the period was £1,201,753.

The profit for the financial period of Abbey Pharmaceuticals Limited was £nil and the aggregate amount of capital and reserves at the end of the period was £1,000.

3

Creditors

Included in the creditors are the following amounts due after more than five years:

 

2014
£

    

2013
£

  

 

   

 

After more than five years by instalments

  

-

    

73,080

 

4

Share capital

Allotted, called up and fully paid shares

 

2014

2013

   

No.

   

£

   

No.

   

£

 

Ordinary of £1 each

 

1,000

   

1,000

   

1,000

   

1,000

 
                         

Page 3